Khalid Alsaleh

1.3k total citations
41 papers, 906 citations indexed

About

Khalid Alsaleh is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Khalid Alsaleh has authored 41 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Khalid Alsaleh's work include Cancer Treatment and Pharmacology (8 papers), HER2/EGFR in Cancer Research (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Khalid Alsaleh is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), HER2/EGFR in Cancer Research (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Khalid Alsaleh collaborates with scholars based in Saudi Arabia, Egypt and Canada. Khalid Alsaleh's co-authors include Abdullah Aldahmash, Nehad M. Alajez, Rimi Hamam, Moustapha Kassem, Musaad Alfayez, Anjum Memon, Dana Hamam, Arwa Ali, Dillwyn Williams and Sara Godward and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Khalid Alsaleh

40 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalid Alsaleh Saudi Arabia 13 443 441 226 103 89 41 906
Rozany Mucha Düfloth Brazil 15 482 1.1× 486 1.1× 366 1.6× 85 0.8× 28 0.3× 44 1.0k
Hideaki Mitsui Japan 18 393 0.9× 206 0.5× 320 1.4× 290 2.8× 51 0.6× 47 863
Sergio Rodrı́guez-Cuevas Mexico 16 362 0.8× 456 1.0× 238 1.1× 89 0.9× 22 0.2× 55 929
Pierre‐Alexandre Just France 17 415 0.9× 222 0.5× 269 1.2× 281 2.7× 46 0.5× 45 1.1k
Derek B. Allison United States 19 290 0.7× 155 0.4× 302 1.3× 214 2.1× 58 0.7× 91 895
Yin‐Hsun Feng Taiwan 20 732 1.7× 476 1.1× 475 2.1× 195 1.9× 83 0.9× 69 1.5k
Rebecca Feldman United States 19 262 0.6× 270 0.6× 568 2.5× 310 3.0× 61 0.7× 68 983
Ran Xie United States 12 295 0.7× 141 0.3× 221 1.0× 185 1.8× 85 1.0× 32 676
Aejaz Nasir United States 17 262 0.6× 142 0.3× 896 4.0× 116 1.1× 33 0.4× 39 1.3k
Andrew P. Sciallis United States 15 225 0.5× 172 0.4× 254 1.1× 162 1.6× 47 0.5× 39 770

Countries citing papers authored by Khalid Alsaleh

Since Specialization
Citations

This map shows the geographic impact of Khalid Alsaleh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Alsaleh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Alsaleh more than expected).

Fields of papers citing papers by Khalid Alsaleh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Alsaleh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Alsaleh. The network helps show where Khalid Alsaleh may publish in the future.

Co-authorship network of co-authors of Khalid Alsaleh

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Alsaleh. A scholar is included among the top collaborators of Khalid Alsaleh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Alsaleh. Khalid Alsaleh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maghrabi, Khalid, et al.. (2023). Prognostic markers in patients with COVID-19 requiring intensive care support. Journal of Taibah University Medical Sciences. 18(5). 1089–1098. 2 indexed citations
2.
Attia, Hala, et al.. (2023). Liraglutide attenuates obese-associated breast cancer cell proliferation via inhibiting PI3K/Akt/mTOR signaling pathway. Saudi Pharmaceutical Journal. 32(1). 101923–101923. 7 indexed citations
3.
4.
Çiçin, İrfan, Amel Mézlini, Slim Ben Ahmed, et al.. (2021). An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction. SHILAP Revista de lepidopterología. 18(1). 63–73. 2 indexed citations
5.
Kepesidis, Kosmas V., Marinus Huber, Sharif Kullab, et al.. (2021). Breast-cancer detection using blood-based infrared molecular fingerprints. BMC Cancer. 21(1). 1287–1287. 13 indexed citations
6.
Azzam, Nahla, Yazed AlRuthia, Othman Alharbi, et al.. (2020). <p>Predictors of Survival Among Colorectal Cancer Patients in a Low Incidence Area</p>. Cancer Management and Research. Volume 12. 451–459. 6 indexed citations
7.
Al-Bahrani, Ahmed Z., et al.. (2020). Establishing hematopoietic stem cell transplant programs; overcoming cost through collaboration. Bone Marrow Transplantation. 55(4). 695–697. 3 indexed citations
8.
Balkhi, Bander, et al.. (2020). Drug utilization and expenditure of anticancer drugs for breast cancer. Saudi Pharmaceutical Journal. 28(6). 669–674. 12 indexed citations
9.
Alsaleh, Khalid, et al.. (2020). Prognostic Significance of HER2 Expression Changes Following Neoadjuvant Chemotherapy in Saudi Patients With Locally Advanced Breast Cancer. Clinical Breast Cancer. 21(4). e362–e367. 1 indexed citations
10.
Alsaleh, Khalid, et al.. (2019). A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).. PubMed. 1(30). 33–42. 4 indexed citations
11.
Alsaleh, Khalid, et al.. (2018). Influence of ABO blood group on von Willebrand factor tests in healthy Saudi blood donors. Blood Coagulation & Fibrinolysis. 29(2). 211–215. 5 indexed citations
12.
Hamam, Rimi, Dana Hamam, Khalid Alsaleh, et al.. (2017). Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. Cell Death and Disease. 8(9). e3045–e3045. 284 indexed citations
13.
Ali, Arwa, et al.. (2016). Triple Negative Breast Cancer: A Tale of Two Decades. Anti-Cancer Agents in Medicinal Chemistry. 17(4). 491–499. 36 indexed citations
14.
Hamam, Rimi, Arwa Ali, Khalid Alsaleh, et al.. (2016). microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection. Scientific Reports. 6(1). 25997–25997. 126 indexed citations
15.
Alsheikh, Ahmed, et al.. (2016). Clinicopathological Features and Predictive Factors for Colorectal Cancer Outcome in the Kingdom of Saudi Arabia. Oncology. 92(2). 75–86. 18 indexed citations
16.
Farooq, Mian Usman, et al.. (2015). Mammographic breast density: Predictive value for pathological response to neoadjuvant chemotherapy in breast cancer patients. The Breast. 24(5). 576–581. 26 indexed citations
17.
Aleem, Aamer, Zahid Shakoor, Khalid Alsaleh, et al.. (2014). Immunological evaluation of β-thalassemia major patients receiving oral iron chelator deferasirox.. PubMed. 24(7). 467–71. 5 indexed citations
18.
Almadi, Majid A., Othman Alharbi, Nahla Azzam, et al.. (2013). Clinical predictors of resectability of pancreatic adenocarcinoma. Saudi Journal of Gastroenterology. 19(6). 278–278. 8 indexed citations
19.
Ellis, Peter & Khalid Alsaleh. (2012). Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions. Critical Reviews in Oncology/Hematology. 84(1). 47–58. 30 indexed citations
20.
Memon, Anjum, et al.. (2001). Epidemiology of reproductive and hormonal factors in thyroid cancer: Evidence from a case‐control study in the Middle East. International Journal of Cancer. 97(1). 82–89. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rozany Mucha Düfloth Breakdown of academic impact, for papers by Hideaki Mitsui Breakdown of academic impact, for papers by Sergio Rodrı́guez-Cuevas Breakdown of academic impact, for papers by Pierre‐Alexandre Just Breakdown of academic impact, for papers by Derek B. Allison Breakdown of academic impact, for papers by Yin‐Hsun Feng Breakdown of academic impact, for papers by Rebecca Feldman Breakdown of academic impact, for papers by Ran Xie Breakdown of academic impact, for papers by Aejaz Nasir Breakdown of academic impact, for papers by Andrew P. Sciallis
Rankless by CCL
2026